Reata's (RETA) Q4 Earnings Miss Mark, Revenues Decline Y/Y
28/2 18:35
Reata Pharmaceuticals, Inc. RETA reported fourth-quarter 2021 loss of $2.35 per share, wider than the Zacks Consensus Estimate of a loss of $2.31....
|
|
|
28/2 18:35
Reata Pharmaceuticals, Inc. RETA reported fourth-quarter 2021 loss of $2.35 per share, wider than the Zacks Consensus Estimate of a loss of $2.31....